Clinical Trial Update: OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD

View source ↗

Summary

This clinical trial update notes that the OPTIMISE-CKD study is evaluating the effectiveness of dapagliflozin in chronic kidney disease and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Status: RECRUITING